Patients in this population benefit from super disintegrants because the tablets are simpler to swallow. These demographics are projected to drive market expansion. Furthermore, generic medications are in high demand since patents on some major prescription names have begun to expire, opening the pharmaceutical sector to increased competition and a rise in generic drug manufacturing, fuelling demand for superdisintegrants. Emerging markets provide enormous opportunities because their healthcare sectors are rapidly expanding. Furthermore, huge patient populations in these countries are projected to drive up the demand for fast-acting drugs. Market companies are likely to establish themselves in the region to take advantage of emerging market prospects.
Superdisintegrants Market Report Overview
MRFR's global superdisintegrants market report contains an entire historical analysis along with current trends to assemble a panoramic view of the market. Drivers, restraints, threats, and opportunities have been expounded in the report along with projections for the future of the market over the forecast period from 2018 to 2023. All parameters relevant to the global superdisintegrants market have been taken into account including the various parts of the market which have been segmented on the basis of types, formulation, therapeutic area, and region. Moreover, various key players operating in the market's competitive landscape have been profiled to provide an impact analysis of various vital growth strategies.
Players Covered
Prominent superdisintegrants market participants that have been profiled in the report include Asahi Kasei Corporation, DFE Pharma, JRS Pharma, Corel Pharma Chem, Ashland Global Holdings Inc., BASF SE, Roquette Freres, DowDuPont Inc., Merck KGaA, and Avantor Performance Materials, LLC
Research Methodology
Market Research Future's market report on the surface disinfectant market has employed various proprietary research methods to ascertain the forecast of the market. Primary data sources such as personal one-on-one interviews with marketing directors, and other important executives, thus providing a deeper insight into industry performance and expectations of the market. Meanwhile, secondary sources of data which refer to both internal and external sources such as customer feedback, analysis of marketing activities, industry publications, annual reports, and others are useful for a full commercial study of the global surface disinfectant market. Moreover, MRFR's data analysts use both top-down and bottom-up approaches for the estimation and validation of Superdisintegrants Market size. All data is processed, analyzed and consolidated into brief palatable reports which include intelligent observations regarding various important Superdisintegrants Market factors. Recent Development
Roquette built a new Pharmaceutical R&D and Customer Technical Service (CTS) in Biopolis (Singapore) in October 2017 for the development of new medicines, new applications for current products, and preclinical research. Roquette's Asia Pacific headquarters is located here, and it concentrates on food, nutrition, and pharmaceutical products. DFE Pharma's supply chain of
pharmaceutical excipients was effectively streamlined in July 2018. Furthermore, the company has made significant investments in factory capacity development to address the global demand for high-quality excipients such as pharmaceutical grade Lactose and Microcrystalline Cellulose (MCC). Ashland launched a new pharmaceutical excipient factory in Nanjing, China, in October 2016, to create excipients for the Asian market. This laboratory provides highly functioning excipient technology to oral pharmaceutical makers as well as tailor-made formulation solutions.
Superdisintegrants Market Segmentation
Type
- Synthetic Superdisintegrants
- Natural Superdisintegrants
- Other Superdisintegrants
Formulation
Therapeutic Area
- Neurological Diseases
- Gastrointestinal Diseases
- Oncology
- Inflammatory Diseases
- Cardiovascular Diseases
- Hematological Diseases
- Infectious Diseases
Region
- Americas
- Europe
- Asia-Pacific
- Middle East & Africa
Report Attribute/Metric |
Details |
Market Size |
USD 720.35 Million |
CAGR |
8.0% |
Base Year |
2021 |
Forecast Period |
2022-2030 |
Historical Data |
2020 |
Forecast Units |
Value (USD Million) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
By Type, Formulation, Therapeutic Area, Region |
Geographies Covered |
North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors |
Asahi Kasei Corporation, DFE Pharma, JRS Pharma, Corel Pharma Chem, Ashland Global Holdings Inc., BASF SE, Roquette Freres, DowDuPont Inc., Merck KGaA, and Avantor Performance Materials, LLC |
Key Market Opportunities |
Joint ventures, strategic alliances, mergers and acquisitions and new product developments |
Key Market Drivers |
· Rising populations of both geriatric patients and pediatric patients· Rise in the manufacturing of generic drugs |